Olympus Valuation Multiples

Olympus Overview

About Olympus

Olympus is a medical-device maker with a leading position in the endoscope market and a diversified global revenue stream. Originally founded in 1919 in Japan as a microscope and camera maker, Olympus has gradually pivoted into endoscopic and therapeutic solutions. As of March 2025, more than 60% of its revenue comes from endoscopic solutions. In addition, North America is the biggest revenue contributor by region, accounting for 38% of its total revenue.

Founded

1919

HQ

Employees

30.0K

Website

olympus.co.jp

Sectors

Medical DevicesDeepTechHealthTech

Financials (LTM)

Revenue: $6B

EBITDA: $1B

EV

$11B

Valuation Multiples

Multiples.vc

Start free trial

Olympus Financials

Olympus reported last 12-month revenue of $6B and EBITDA of $1B.

In the same LTM period, Olympus generated $4B in gross profit, $1B in EBITDA, and $386M in net income.

Olympus P&L

In the most recent fiscal year, Olympus reported revenue of $7B and EBITDA of $2B.

Olympus expects next 12-month revenue of XXX and NTM EBITDA of XXX

Olympus Stock Performance

Olympus has current market cap of $11B, and enterprise value of $11B.

Olympus' stock price is $9.98.

Olympus Valuation Multiples

Olympus trades at 1.8x EV/Revenue multiple, and 11.1x EV/EBITDA.

Olympus Financial Valuation Multiples

As of April 19, 2026, Olympus has market cap of $11B and EV of $11B.

Equity research analysts estimate Olympus' 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Olympus has a P/E ratio of 28.4x.

Olympus Margins & Growth Rates

Olympus' revenue in the last 12 month grew by 5%.

Olympus' revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.1M for the same period.

Olympus' rule of 40 is 23% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Olympus' rule of X is 28% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Olympus Public Comps

See public comps and valuation multiples for other Medical Devices comps.

Olympus M&A Activity

Olympus acquired XXX companies to date.

Last acquisition by Olympus was on XXXXXXXX, XXXXX. Olympus acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).

Olympus Investment Activity

Olympus invested in XXX companies to date.

Olympus made its latest investment on XXXXXXXX, XXXXX. Olympus invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).